News
-
-
-
COMMUNIQUÉ DE PRESSE
Just – Evotec Biologics Advances U.S. Department of War Antibodies Against Orthopoxvirus into Phase 1 Clinical Studies
Just \/ Evotec Biologics advances investigational antibodies against orthopoxviruses into Phase 1 clinical studies under U.S. Department of War Accelerated Antibodies Program, supporting biodefense preparedness -
-
-
COMMUNIQUÉ DE PRESSE
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
Evotec SE and Plectonic Biotech collaborate on a new T-cell-engaging immunotherapy approach for solid tumors, combining BiTco costimulatory platform with LOGIBODY technology -
-
-
-
